Skip to main content
OpenTrials
Completed

NCT Number: NCT02068664

An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia

The purpose of this study is to determine if stroke survivors with aphasia have spatial neglect (Phase 1). If they are determined to have the condition Phase 2 will be offered: which is prism adaptation treatment. This is a pilot study that will be performed with 4-5 subjects.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Spatial Neglect Aphasia Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Communication Disorders Language Disorders Nervous System Diseases Neurobehavioral Manifestations Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms Speech Disorders Stroke Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Adler Aphasia Center

Maywood, New Jersey, 07607, United States

About this study

Spatial neglect is a disorder that may occur after a brain injury such as stroke. Spatial neglect may affect stroke recovery. One example of this heterogeneous condition: Individuals with spatial neglect often pay more attention to one side of what they are looking at, even though they have no difficulty seeing. The study investigators would like to screen stroke survivors with aphasia because they may also have spatial neglect (right neglect after left hemisphere stroke), which is said by the literature to occur in 25% of cases. If it is identified, a treatment approach will be offered, to attempt to remediate the condition using prism goggles, following a prism treatment protocol based on previous studies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • A stroke survivor with aphasia who is a member at the Adler Aphasia Center

Exclusion criteria

  • Has a history of brain tumor, head injury with loss of consciousness, dementia, alzheimers

Treatment and study plan

Prism Adaptation Treatment

Behavioral

Prism goggles shift the image one sees toward the left (because the thicker portion of the glass lens is on the right). This will change the perception of where the image is in space, causing the person to adapt. The after-effects of the treatment is what is important. It has been shown to make it easier for people to move in the right space (if have right neglect) or improves ability to complete other functional tasks.

Primary outcomes

  1. Kessler Foundation Neglect Assessment Process

    Time frame: 2 weeks

    a performance based and behavioral measure for spatial neglect that utilizes and standardizes the administration of the Catherine Bergego Scale (CBS)

Secondary outcomes

  1. Behavior Inattention Test

    Time frame: 2 weeks

    Conventional subtest, a set of paper and pencil test for spatial neglect

  2. Barthel Index

    Time frame: 2 weeks

    A functional independence assessment of daily tasks

  3. University of Alabama at Birmingham (UAB) Life Space assessment

    Time frame: 2 weeks

    a self graded assessment on community mobility and participation

Sponsors and collaborators

Lead sponsor

Kessler Foundation

Other

Registry information

Official study title

An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia With Option of Prism Adaptation Treatment (PAT) Protocol

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Feb 21, 2014
Registry last updated
Aug 21, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.